Ibsa Institut Biochimique SA

IBSA (Institut Biochimique SA) is a Swiss pharmaceutical company founded in 1945 in Lugano. Today it is present with its products in over 90 countries on 5 continents and has 17 branches located in Europe, China and the United States. The company has a consolidated turnover of CHF 800 million and employs more than 2,000 people between headquarters, subsidiaries and production sites. IBSA holds 90 approved patent families and others in development and a wide range of products that cover 10 therapeutic areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, uro-gypology, cardiometabolic, respiratory, consumer health. He is also one of the world's leading players in reproduction medicine and one of the world leaders in hyaluronic acid products. The pillars on which IBSA founded its philosophy are: Person, Innovation, Quality and Responsibility.

CONTACT

Aesthetic Medicine aims to improve and maintain the aesthetic well-being of the skin through a precise analysis of the general and local conditions of the patient, the formulation of accurate diagnosis and the elaboration of therapeutic strategies.

The area offers a complete range of products based on Hydrolift® action concept. Hydrolift® Action is an innovative approach to counteract the physiological decrease of hyaluronic acid (hyaluronic acid - HA) present in the skin, restoring hydration, elasticity and tone.

This approach is an expression of synergistic action derived from the use of selected hyaluronic acids and products with patented technology that, administered in combination, create the optimal conditions to prevent and counteract the aging process.

The line has been expanded in recent years with an innovative product containing a solution of cooperative hybrid complexes of ultra-purple hyaluronic acid, thermally stabilized. . .